VIVAZEN appoints Dr. Paloma Lehfeldt

VIVAZEN Appoints First-Ever Medical Director to Drive Scientific Advancements

Sep 10, 2024

0 Comments

Key Takeaways:

  • VIVAZEN appoints Dr. Paloma Lehfeldt as its first Senior Director of Medical Science.
  • Dr. Lehfeldt will lead medical and scientific advancements, research partnerships, and public engagement for VIVAZEN's product lineup.
  • Dr. Lehfeldt brings 15+ years of experience in plant medicine research and education.

VIVAZEN®, a leading brand in the herbal supplement market, has announced the appointment of Dr. Paloma Lehfeldt, M.D., M.A., as its Senior Director of Medical Science.

This is the first time VIVAZEN has established such a role, with Dr. Lehfeldt charged with advancing the medical and scientific aspects of the brand’s botanical product lineup.

ALSO READ: The van Breemen Company Launches, Focuses on Plant Based Medicine

With more than 15 years of experience in plant medicine research, Dr. Lehfeldt will oversee the development of VIVAZEN’s scientific education, research partnerships, and community outreach.

She will also contribute to product development and lead public engagement efforts to emphasize the safety and quality of VIVAZEN’s products.

Prior to joining VIVAZEN, Dr. Lehfeldt served as Senior Director of Clinical Science and Partnerships at Vireo Health, where she led social equity initiatives and chaired diversity, equity, and inclusion efforts.

VIVAZEN's Chief Marketing Officer, Natalie Gershon, emphasized that Dr. Lehfeldt's appointment aligns with the company’s commitment to product safety and scientific innovation.

Dr. Lehfeldt expressed enthusiasm for her new role, highlighting the growing recognition of plant-based medicine and VIVAZEN’s position at the forefront of this movement.